Bioporto A/S BIOPOR-DK:Copenhagen Stock Exchange

RT Quote | Exchange | DKK
Last | 11:48 AM CET
5.38quote price arrow up+0.22 (+4.26%)
Volume
515,956
52 week range
4.40 - 8.24

...

Loading . . .

KEY STATS

  • Open5.14
  • Day High5.44
  • Day Low5.10
  • Prev Close1.82
  • 52 Week High8.24
  • 52 Week High Date01/20/21
  • 52 Week Low4.40
  • 52 Week Low Date01/05/21
  • Market Cap197.26M
  • Shares Out238.05M
  • 10 Day Average Volume1.97M
  • Dividend-
  • Dividend Yield-
  • Beta1.27
  • 1 Year % Change139.54

RATIOS/PROFITABILITY

  • EPS (TTM)-0.31
  • P/E (TTM)-17.35
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Bioporto A/S News

There is no recent news for this security.

Latest BIOPOR-DK News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Bioporto A/S is a Denmark-based company engaged in the development and marketing of in vitro diagnostic (IVD) assays. The Company’s portfolio comprises five product categories: The Neutrophil gelatinase-associated lipocalin (NGAL) Test, which is a test for diagnosing acute kidney injury; NGAL Enzyme-linked immunosorbent assay (ELISA) kits, which supplies NGAL for the development of medicines for estimating side-effects that are harmful to kidneys; Mannan-binding Lectin (MBL)...
Thomas Magnussen
Chairman
Torben Nielsen
Vice Chairman
Peter Moerch Eriksen
Chief Executive Officer
Jan Kuhlmann Andersen
Chief Operating Officer
Ole Larsen
Chief Financial Officer
Finn Fjorder
Executive Vice President
Address
Tuborg Havnevej 15, St.
Hellerup
2900
Denmark